Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy
Mohamed J. Saadh, M. V. Mikhailova, Soheil Rasoolzadegan, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Exploring the ethical considerations of using Chat GPT in university education
et. al. Jorge Jinchuña Huallpa
Periodicals of Engineering and Natural Sciences (PEN) (2023) Vol. 11, Iss. 4, pp. 105-105
Open Access | Times Cited: 65
Assessing the drug delivery of ibuprofen by the assistance of metal-doped graphenes: Insights from density functional theory
Sahar Esfahani, Jafar Akbari, Somayeh Soleimani‐Amiri, et al.
Diamond and Related Materials (2023) Vol. 135, pp. 109893-109893
Closed Access | Times Cited: 34
Recent advances in biomaterials for tissue-engineered constructs: Essential factors and engineering techniques
Shiva Norouzi, Nikoo Saveh Shemshaki, Ehsan Norouzi, et al.
Materials Today Chemistry (2024) Vol. 37, pp. 102016-102016
Open Access | Times Cited: 13
The impact of interleukin-6 (IL-6) and mesenchymal stem cell-derived IL-6 on neurological conditions
Irina Kerkis, Álvaro Rossan de Brandão Prieto da Silva, Rodrigo Pinheiro Araldi
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Biomaterials for inflammatory bowel disease: treatment, diagnosis and organoids
Jia Wang, Yuying Shi, Bei Mao, et al.
Applied Materials Today (2024) Vol. 36, pp. 102078-102078
Closed Access | Times Cited: 9
Tedizolid phosphate alleviates DSS-induced ulcerative colitis by inhibiting senescence of cell and colon tissue through activating AMPK signaling pathway
Min Zhou, Zhenlin Liu, Jiayu Liu, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112286-112286
Closed Access | Times Cited: 8
Recent advances in mesenchymal stem cell therapy for multiple sclerosis: clinical applications and challenges
Kamran Sheikhi, Sara Ghaderi, Hassan Firouzi, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access | Times Cited: 1
Mesenchymal Stromal Cells: New Generation Treatment of Inflammatory Bowel Disease
Shulin Wei, Mingxing Li, Qin Wang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3307-3334
Open Access | Times Cited: 7
Advancements and Challenges in Stem Cell Transplantation for Regenerative Medicine
Lingxi Wei, Wenqi Yan, Wahid Shah, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35836-e35836
Open Access | Times Cited: 7
Therapeutic potential of mesenchymal stem cell‐derived extracellular vesicles: A focus on inflammatory bowel disease
L Clua-Ferré, R Suau, Irene Vañó‐Segarra, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 11
Open Access | Times Cited: 5
Exploring the Potential of Stem Cells in Modulating Gut Microbiota and Managing Hypertension
Asma Ismail Mahmod, Kayatri Govindaraju, Yogeswaran Lokanathan, et al.
Stem Cells and Development (2025)
Closed Access
Zataria multiflora Hydroalcoholic Extract: A Triple-Blind Randomized Controlled Trial on Immune Genes, Inflammation, and Ulcerative Colitis Symptoms
Mehrnaz Morvaridi, Naheed Aryaeian, Pezhman Alavine­jad, et al.
Journal of Ethnopharmacology (2025), pp. 119527-119527
Closed Access
Long-acting injectable nanoparticle formulation for sustained release of anti-TNF-α antibody therapeutic in ulcerative colitis treatment
Yicheng Zhang, Ling Li, Jiayuan Kong, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 1005-1016
Closed Access
Human Umbilical Cord-Derived Mesenchymal Stem Cells Attenuate Liver Fibrosis by Inhibiting Hepatocyte Ferroptosis Through Mitochondrial Transfer
Zhiyu Xiong, Ping Chen, Zheng Wang, et al.
Free Radical Biology and Medicine (2025) Vol. 231, pp. 163-177
Open Access
Mesenchymal Stem Cells Armed with DNA Nanorobots as a Modality for Combination Therapy of Inflammatory Bowel Disease
Hongxiu Yuan, Gang Wang, Fangbo Zou, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Assembly of MSCs into a spheroid configuration increases poly(I:C)-mediated TLR3 activation and the immunomodulatory potential of MSCs for alleviating murine colitis
C.‐W. Ho, Ying‐Chi Kao, Yueh-Ming Shyu, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Extracellular Vesicles: A Crucial Player in the Intestinal Microenvironment and Beyond
Shumeng Wang, Junyi Luo, Hailong Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3478-3478
Open Access | Times Cited: 4
Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches
Catherine O’Reilly, Susan Mills, Mary C. Rea, et al.
Microbiome Research Reports (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 9
hP-MSCs attenuate severe acute pancreatitis in mice via inhibiting NLRP3 inflammasome-mediated acinar cell pyroptosis
Shuang Lyu, Shuirong Liu, Xin Guo, et al.
APOPTOSIS (2024) Vol. 29, Iss. 5-6, pp. 920-933
Closed Access | Times Cited: 3
Gastrointestinal Disease: New Diagnostic and Therapeutic Approaches
Beata Jabłońska, Sławomir Mrowiec
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1420-1420
Open Access | Times Cited: 8
Mesenchymal Stem Cells in the Treatment of COVID-19
Bei-Cyuan Guo, Kang‐Hsi Wu, Chun‐Yu Chen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14800-14800
Open Access | Times Cited: 7
The NLRP3 molecule influences the therapeutic effects of mesenchymal stem cells through Glut1-mediated energy metabolic reprogramming
Jingrou Chen, Shu‐Juan Xie, Dongbo Qiu, et al.
Journal of Advanced Research (2023) Vol. 65, pp. 125-136
Open Access | Times Cited: 7
Updates and Challenges in ENS Cell Therapy for the Treatment of Neurointestinal Diseases
Takahiro Ohkura, Alan J. Burns, Ryo Hotta
Biomolecules (2024) Vol. 14, Iss. 2, pp. 229-229
Open Access | Times Cited: 2
Mesenteric lymph nodes: a critical site for the up-regulatory effect of hUC-MSCs on Treg cells by producing TGF-β1 in colitis treatment
Qixiang Zhang, Zhu Zeng, Ning Wei, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
The Roles of Flavonoids in the Treatment of Inflammatory Bowel Disease and Extraintestinal manifestations : A Review
Xu Gao, Xi Feng, Tao Hou, et al.
Food Bioscience (2024) Vol. 62, pp. 105431-105431
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top